Pharmacy News

Subscribe to Pharmacy News feed
PharmaTimes - The latest news in healthcare and life sciences - News RSS
Updated: 50 min 18 sec ago

Final chance to enter into the 2019 Sales Awards!

The 2019 PharmaTimes Sales Awards will be closing for entry on Friday – this is the last chance for sales professionals to enter.

Cassava’s lead Alzheimer’s candidate hits endpoints

The new treatment could be an "important part of the research dialogue in Alzheimer’s disease.”

Bayer’s two-year data confirms Eylea effectiveness

Wet AMD is a serious and debilitating sight-threatening condition that requires ongoing treatment to prevent worsening.

Spravato reduces depressive symptoms in 24 hours

Both studies showed clinically meaningful and statistically significant superiority of the drug.

PRAC to review Picato skin cancer data

The committee will now carry out a thorough review of all available data, including from ongoing studies.

NHS to review making statins available for pharmacists

If only 45% of people with a high risk of cardiovascular disease were identified and treated, 6,000 strokes and heart attacks could be avoided over the next ten years.

Novartis confirms long-term efficacy, safety of Aimovig

Back in April the SMC accepted the drug for use in patients with chronic migraine.

EQL accepted by NHS accelerator programme

Earlier this year, EQL launched its debut product ‘Phio’, a chatbot that thinks and acts like a physiotherapist.

NHS to roll out high street heart checks

Cardiovascular disease costs the NHS £7 billion a year.

Imfinzi shows survival benefit in aggressive lung cancer

The drug cut the risk of death by 27%.

Only 1 week left to enter into the 2019 Sales Awards!

There is now only 1 week left to secure your place in the 2019 Sales Awards, which will be closing for entry on Friday the 13th of September.

EU Marketing Authorisation granted for Lonsurf

The approval is a “landmark decision for patients across the European Union."

LIVI partners with Boots

The NHS Long Term Plan states that all patients should have access to online and video consultations by 2021.

EU approval for Tecentriq-based NSCLC combo

The drug is a monoclonal antibody designed to bind with a protein called PD-L1.

Keytruda combo bags EU approval in RCC

The combo reduced the risk of death by 47% in a clinical trial.

Spending Round provides ‘much-needed’ NHS funding

The NHS will recieve a cash increase of £33.9 billion a year by 2023-24 compared to 2018-19 budgets.

AstraZeneca, Theranostics sign PARPi development agreement

The licensing agreement enables the company’s “freedom to operate globally in the diagnostic field of certain selected radionuclide-labelled PARPi.”

Snack tax could be ‘more effective’ than sugary drink tax

The news comes after Cancer Research UK found that obesity causes more cases of certain cancers than smoking.

Breakthrough Designation granted for Janssen’s RSV vaccine

RSV is a highly prevalent, very contagious respiratory infection and a leading cause of bronchitis and pneumonia.

J&J launches ‘Make Blood Cancer Visible’ campaign

The company has released a short documentary and five mini-films, outlining the symptoms that led patients to their diagnosis.